Literature DB >> 20659140

Unsedated transnasal ultrathin esophagogastroduodenoscopy may provide better diagnostic performance in gastroesophageal reflux disease.

A Mori1, N Ohashi, A Yoshida, M Nozaki, H Tatebe, M Okuno, Y Hoshihara, M Hongo.   

Abstract

Transnasal ultrathin esophagogastroduodenoscopy (N-EGD) with less gagging reflexes under non-sedation is likely suitable for the diagnosis of gastroesophageal reflux disease (GERD), however, N-EGD might have drawbacks, including its low image resolution. Limited information is available regarding the diagnosability of N-EGD for GERD. We compared the utility and gagging reflexes of three different endoscopies, including N-EGD, ultrathin transoral EGD (UTO-EGD) and conventional oral EGD (CO-EGD), in the diagnosis of GERD. We performed screening endoscopy in 1580 patients (N-EGD n=727, UTO-EGD n=599, CO-EGD n=254) and compared the frequency distributions of the severity of reflux esophagitis, hiatus hernia, and Barrett's epithelium to estimate the diagnostic performance of each endoscopy. We also analyzed patients' tolerability of endoscopy by the subjective evaluation of gagging reflexes. In the diagnosis of reflux esophagitis and Barrett's epithelium, there was no significant difference in the frequency distributions of the severity of the diseases among three EGDs. However, the incidence of Barrett's epithelium was higher than that in the previous nationwide survey of GERD in Japan. The evaluated size of hiatus hernia was smaller in N-EGD than in two other peroral endoscopies. The size of hiatus hernia correlated significantly with severity of gagging reflexes that was also lowest when diagnosed with N-EGD. N-EGD had an equivalent performance in the diagnosis of reflux esophagitis and Barrett's epithelium compared with CO-EGD. Enlargement of hiatus hernia induced by gagging reflexes was minimal in N-EGD, resulting in its better performance in the diagnosis of Barrett's epithelium.
© 2010 Copyright the Authors. Journal compilation © 2010, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Year:  2011        PMID: 20659140     DOI: 10.1111/j.1442-2050.2010.01098.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

Review 1.  Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-07-06       Impact factor: 8.262

2.  Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video).

Authors:  Anne F Peery; Toshitaka Hoppo; Katherine S Garman; Evan S Dellon; Norma Daugherty; Susan Bream; Alejandro F Sanz; Jon Davison; Melissa Spacek; Diane Connors; Ashley L Faulx; Amitabh Chak; James D Luketich; Nicholas J Shaheen; Blair A Jobe
Journal:  Gastrointest Endosc       Date:  2012-03-16       Impact factor: 9.427

3. 

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

4.  Transnasal endoscopy: no gagging no panic!

Authors:  Clare Parker; Estratios Alexandridis; John Plevris; James O'Hara; Simon Panter
Journal:  Frontline Gastroenterol       Date:  2015-07-02

Review 5.  Propofol sedation during endoscopic treatment for early gastric cancer compared to midazolam.

Authors:  Shinsuke Kiriyama; Hiroshi Naitoh; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

6.  Necessity of transnasal gastroscopy in routine diagnostics: a patient-centred requirement analysis.

Authors:  Anna-Livia Schuldt; Holger Kirsten; Jan Tuennemann; Mario Heindl; Florian van Bommel; Juergen Feisthammel; Marcus Hollenbach; Albrecht Hoffmeister
Journal:  BMJ Open Gastroenterol       Date:  2019-04-14

Review 7.  Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).

Authors:  Candyce Hamel; Nadera Ahmadzai; Andrew Beck; Micere Thuku; Becky Skidmore; Kusala Pussegoda; Lise Bjerre; Avijit Chatterjee; Kristopher Dennis; Lorenzo Ferri; Donna E Maziak; Beverley J Shea; Brian Hutton; Julian Little; David Moher; Adrienne Stevens
Journal:  Syst Rev       Date:  2020-01-29

8.  Public acceptance and uptake of oesophageal adenocarcinoma screening strategies: A mixed-methods systematic review.

Authors:  Jasmijn Sijben; Yonne Peters; Kim van der Velden; Linda Rainey; Peter D Siersema; Mireille J M Broeders
Journal:  EClinicalMedicine       Date:  2022-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.